News

Event: Community Involvement in TB Drug Development: A roundtable discussion


23 May 2010
by Working Group

A Satellite Session at the 2nd TB Conference
June 3, 2010; 16:00 – 18:00
MR 11, ICC, Durban

Community engagement in TB drug research is growing practice, made possible by the fact that several new drug candidates are entering clinical trials. This roundtable will provide a forum for dialogue between researchers, community members, CBOs/NGOs, and advocates about methods for effective community engagement in TB research. Panelists representing several viewpoints will highlight successful practices for encouraging stakeholder involvement in research and discuss how communities can influence national policies and procedures to ensure the rapid adoption and roll-out of new TB regimens, once available.


Moderator:
Javid Syed, Treatment Action Group

Panel Presentations:

  • Research Literacy: A fundamental component of community engagement — Paula Akugizibwe, AIDS Rights Alliance South Africa (invited)
  • Community Outreach: A researcher’s perspective — Dr. Gavin Churchyard, Aurum Institute
  • Best Practices for Community Engagement in TB Drug Research — Dr. Jane Ong’ang’o, Kenya Medical Research Institute
  • Working with Local Government — Doctor Nuglube, Lusaka University Teaching Hospital Community Advisory Board
  • Advocacy for Policy Change — Nathan Geffen, Treatment Action Campaign

Panel presentations will be followed by open discussion. Light refreshments will be provided.

To indicate your interest in attending, please email rsvp@tballiance.org


TB Alliance
Sponsored by the TB Alliance

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...